Assay News and Research

RSS
Serological antibody response to SARS-CoV-2 infection at a population level

Serological antibody response to SARS-CoV-2 infection at a population level

Streamlined, efficient approaches to cell culture spectrometry and analysis

Streamlined, efficient approaches to cell culture spectrometry and analysis

Does SARS-CoV-2 Omicron variant elicited neutralizing immunity enhance that elicited by the Delta variant?

Does SARS-CoV-2 Omicron variant elicited neutralizing immunity enhance that elicited by the Delta variant?

COVID boosters hinder SARS-CoV-2 Omicron

COVID boosters hinder SARS-CoV-2 Omicron

Booster dose elicits cross-reactive humoral immunity against SARS-CoV-2 Delta and Omicron variants

Booster dose elicits cross-reactive humoral immunity against SARS-CoV-2 Delta and Omicron variants

New CRISPR-based assay can non-invasively detect a biomarker of acute kidney rejection in urine

New CRISPR-based assay can non-invasively detect a biomarker of acute kidney rejection in urine

Exploring SARS-CoV-2-like viruses to mitigate the risk of zoonotic transmission to humans

Exploring SARS-CoV-2-like viruses to mitigate the risk of zoonotic transmission to humans

Exploring vaccine-induced cellular immunity against SARS-CoV-2 Omicron variant

Exploring vaccine-induced cellular immunity against SARS-CoV-2 Omicron variant

COVID-19 mRNA vaccines offer protection against Omicron variant in pregnancy

COVID-19 mRNA vaccines offer protection against Omicron variant in pregnancy

Nucleocapsid protein preferentially binds to structured and longer RNA to deliver viral proteins in host circulation

Nucleocapsid protein preferentially binds to structured and longer RNA to deliver viral proteins in host circulation

Can the COVID-19 delta variant evade vaccine-induced immunity?

Can the COVID-19 delta variant evade vaccine-induced immunity?

mRNA booster vaccine confers strong protection against SARS-CoV-2 Omicron in cancer patients

mRNA booster vaccine confers strong protection against SARS-CoV-2 Omicron in cancer patients

Time since COVID vaccination is a key driver of breakthrough Omicron infections

Time since COVID vaccination is a key driver of breakthrough Omicron infections

Sino Biological Deposits Recombinant Omicron Proteins and Antibodies to BEI Resources

Sino Biological Deposits Recombinant Omicron Proteins and Antibodies to BEI Resources

T-cell responses to SARS-CoV-2 Omicron variant confer protection to vaccinated individuals

T-cell responses to SARS-CoV-2 Omicron variant confer protection to vaccinated individuals

COVID-19 tests with the new assay may be just as reliable as laboratory-based molecular tests

COVID-19 tests with the new assay may be just as reliable as laboratory-based molecular tests

SARS-CoV-2 Omicron study on hamsters, shows virus results in a less severe disease

SARS-CoV-2 Omicron study on hamsters, shows virus results in a less severe disease

NAbs activity against SARS-CoV-2 variants, including Omicron, in an elderly vaccinated cohort

NAbs activity against SARS-CoV-2 variants, including Omicron, in an elderly vaccinated cohort

Study shows structural and functional aspects of antibody neutralization of SARS-CoV-2 Omicron variant

Study shows structural and functional aspects of antibody neutralization of SARS-CoV-2 Omicron variant

Altered cytokine profiles of COVID-19-infected mother-infant dyads may impair long-term infant health

Altered cytokine profiles of COVID-19-infected mother-infant dyads may impair long-term infant health